Recent News

By Category: Research

US health security research not balanced enough to meet goals, study suggests

(Medical Xpress) Federal support for health security research is heavily weighted toward preparing for bioterrorism and other biological threats, providing significantly less funding for challenges such as monster storms or attacks with conventional bombs, according to a new RAND Corporation study. The findings, published in the December issue of the journal Health Affairs, come from  Read More »

New study sheds light on how Salmonella spreads in the body

(EurekAlert) Findings of Cambridge scientists, published today in the journal PLoS Pathogens, show a new mechanism used by bacteria to spread in the body with the potential to identify targets to prevent the dissemination of the infection process. Salmonella enterica is a major threat to public health, causing systemic diseases (typhoid and paratyphoid fever), gastroenteritis  Read More »

'Globalisation & climate change affecting food security' – Economic Times

'Globalisation & climate change affecting food security'Economic TimesDr Sharma, director of plant biosecurity at the Department of Agriculture and Food in western Australia, said the increase in rapid transport systems and movement of people and goods, accompanied by climate change has increased the threat of new pests …and more »

Proposed H5N1 Research Reviews Raise Concerns

(Science Mag) Researchers are giving a mixed reception to a draft U.S. government plan to do more stringent funding reviews of certain kinds of H5N1 avian influenza research—and perhaps even require some studies to be kept secret. The proposal, presented last week at a meeting of the National Science Advisory Board for Biosecurity, is the  Read More »

National Institute of Health Awards Contract to Support Use of iBio’s Proprietary Technology for Improved Anthrax Vaccine

(Sacramento Bee) In October 2012, iBio announced issuance of a U.S. patent covering compositions of matter and methods of producing anthrax vaccines, an expansion of the Company’s portfolio of assets relevant to bio-defense and infectious disease product applications. Data previously published in peer-reviewed scientific journals demonstrated the effectiveness of the iBioLaunch platform for development and  Read More »